Last Price
9.48
Today's Change
+4.59 (93.86%)
Day's Change
6.16 - 12.40
Trading Volume
94,666,959
Market Cap
581 Million
Shares Outstanding
61 Million
Avg Volume
349,351
Avg Price (50 Days)
5.62
Avg Price (200 Days)
5.30
PE Ratio
-4.27
EPS
-2.22
Earnings Announcement
07-Nov-2024
Previous Close
4.89
Open
6.39
Day's Range
6.16 - 12.4
Year Range
2.765 - 12.4
Trading Volume
94,850,892
1 Day Change
93.86%
5 Day Change
80.23%
1 Month Change
83.37%
3 Month Change
103.00%
6 Month Change
77.86%
Ytd Change
66.02%
1 Year Change
205.81%
3 Year Change
-65.08%
5 Year Change
-55.24%
10 Year Change
-55.24%
Max Change
-55.24%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts.